500 related articles for article (PubMed ID: 2901773)
21. Thyroid C-cell hyperplasia and micronodules in close relatives of MEN-2A patients: pitfalls in early diagnosis and reevaluation of criteria for surgery.
Lips CJ; Leo JR; Berends MJ; Minder WH; Blok AP; Geerdink RA; Hackeng WH; Roelofs JM; Vasen HF; Vette JK
Henry Ford Hosp Med J; 1987; 35(2-3):133-8. PubMed ID: 2891645
[No Abstract] [Full Text] [Related]
22. [Sipple syndrome (bilateral phaeochromocytoma medullary C-cell carcinoma of the thyroid gland) with exceptionally prolonged clinical course].
Kovarik J; Silberbauer K; Woloszczuk W; Krisch K; Geyer G
Wien Klin Wochenschr; 1982 Jun; 94(13):340-5. PubMed ID: 6127842
[TBL] [Abstract][Full Text] [Related]
23. [Medullary cancer of the thyroid and multiple endocrine neoplastic syndromes].
Delisle MJ
Rev Prat; 1992 Apr; 42(7):845-50. PubMed ID: 1351314
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of calcitonin and carcinoembryonic antigen doubling times in medullary thyroid carcinoma.
Jackson CE; Norum RA; Talpos GB; Feldkamp CS; Tashjian AH
Henry Ford Hosp Med J; 1987; 35(2-3):120-1. PubMed ID: 2891643
[No Abstract] [Full Text] [Related]
25. [Sporadic and hereditary medullary carcinoma of the thyroid. Multiple endocrine neoplasia, types MEN II A and B].
Saegesser F; Chabloz R; Bischoff T; Saraga P; Loosli H; Scazziga B; Burckhardt P
Chirurgie; 1983; 109(4):310-23. PubMed ID: 6138219
[No Abstract] [Full Text] [Related]
26. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
[TBL] [Abstract][Full Text] [Related]
27. [Problems posed by the detection of familial medullary cancer of the thyroid in children].
Delépine N; Desbois JC
Biomed Pharmacother; 1984; 38(9-10):434-9. PubMed ID: 6152183
[TBL] [Abstract][Full Text] [Related]
28. [Preoperative cytologic diagnosis of medullary carcinoma of the thyroid].
Rabitti C; Fadda G; Minimo C; Coronetta F; Russo RM; Capelli A
Pathologica; 1989; 81(1072):171-7. PubMed ID: 2570396
[TBL] [Abstract][Full Text] [Related]
29. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
30. [Medullary cancer of the thyroid gland].
Chabloz R; Bischoff T; Saraga P; Loosli H; Scazziga B; Burckhardt P; Saegesser F
Schweiz Med Wochenschr; 1983 Jun; 113(22):814-23. PubMed ID: 6136090
[TBL] [Abstract][Full Text] [Related]
31. [Medullary thyroid carcinoma and some of its particularities].
Sidibé el H
Sante; 2007; 17(1):51-5. PubMed ID: 17897902
[TBL] [Abstract][Full Text] [Related]
32. Medullary carcinoma of the thyroid. (Clinical and endocrinological features of six cases).
degli Uberti EC; Trasforini G; Bagni B; Liboni A; Pansini GC; Altavilla G
Ric Clin Lab; 1981; 11(2):171-8. PubMed ID: 7268276
[TBL] [Abstract][Full Text] [Related]
33. Management of medullary thyroid carcinomas.
Hamoir M; Maisin JP; Warnier P; Ketelslegers JM; Rahier J
Acta Otorhinolaryngol Belg; 1987; 41(5):782-92. PubMed ID: 2899945
[No Abstract] [Full Text] [Related]
34. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid].
Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E
Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336
[TBL] [Abstract][Full Text] [Related]
35. Multiple endocrine neoplasia type 2b with a good prognosis.
Kullberg BJ; Nieuwenhuijzen Kruseman AC
Arch Intern Med; 1987 Jun; 147(6):1125-7. PubMed ID: 2884942
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid cancer in a Wisconsin kindred with Sipple's syndrome: the use of provoked calcitonin testing.
Witte RS; Starling JR; Warner T; Davis TE
Wis Med J; 1982 Nov; 81(11):22-5. PubMed ID: 6130656
[No Abstract] [Full Text] [Related]
37. [Clinical signs in medullary cancers of the thyroid].
Delisle MJ; Gardet P; Laplanche A; Rougier P; Parmentier C
Bull Cancer; 1984; 71(3):165-71. PubMed ID: 6148974
[TBL] [Abstract][Full Text] [Related]
38. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
[TBL] [Abstract][Full Text] [Related]
39. [Usefulness of calcitonin measurement for the diagnosis of medullary cancer of the thyroid in a family with multiple endocrine adenoma syndrome of type IIB].
Pumarino H; Riesco J; Michelsen H; Campino C; Cembal J; Generini G
Rev Med Chil; 1984 Jul; 112(7):675-80. PubMed ID: 6151224
[No Abstract] [Full Text] [Related]
40. Results of a screening program for multiple endocrine neoplasia type 2A: a clinical study of a Japanese family.
Shimotake T; Iwai N; Yanagihara J; Kobayashi T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):124-6. PubMed ID: 2576943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
